American Research & Management Company’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $26K | Hold |
2,000
| – | – | 0.01% | 238 |
|
|
2022
Q2 | $28K | Hold |
2,000
| – | – | 0.01% | 232 |
|
|
2022
Q1 | $29K | Hold |
2,000
| – | – | 0.01% | 236 |
|
|
2021
Q4 | $27K | Hold |
2,000
| – | – | 0.01% | 244 |
|
|
2021
Q3 | $33K | Hold |
2,000
| – | – | 0.01% | 228 |
|
|
2021
Q2 | $34K | Hold |
2,000
| – | – | 0.01% | 234 |
|
|
2021
Q1 | $37K | Hold |
2,000
| – | – | 0.01% | 212 |
|
|
2020
Q4 | $36K | Hold |
2,000
| – | – | 0.01% | 218 |
|
|
2020
Q3 | $36K | Hold |
2,000
| – | – | 0.01% | 200 |
|
|
2020
Q2 | $36K | Hold |
2,000
| – | – | 0.01% | 205 |
|
|
2020
Q1 | $30K | Buy |
2,000
+1,940
| +3,233% | +$29.1K | 0.01% | 201 |
|
|
2019
Q4 | $1K | Buy |
+60
| New | +$1K | ﹤0.01% | 328 |
|
|
2019
Q2 | – | Sell |
-745
| Closed | -$15K | – | 372 |
|
|
2019
Q1 | $15K | Buy |
+745
| New | +$15K | ﹤0.01% | 303 |
|